| 1 |
35548336 | Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells. | 2022 |
4 |
| 2 |
32385805 | Involvement of Histamine 2 Receptor in Alpha 1 Adrenoceptor Mediated Cardiac Hypertrophy and Oxidative Stress in H9c2 Cardio Myoblasts. | 2021 Feb |
1 |
| 3 |
33206207 | Histamine receptors and COVID-19. | 2021 Jan |
1 |
| 4 |
33833683 | COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. | 2021 |
1 |
| 5 |
34686215 | Famotidine promotes inflammation by triggering cell pyroptosis in gastric cancer cells. | 2021 Oct 22 |
1 |
| 6 |
34735523 | Effect of famotidine on hospitalized patients with COVID-19: A systematic review and meta-analysis. | 2021 |
1 |
| 7 |
32702719 | COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. | 2020 Jun 22 |
1 |
| 8 |
30169806 | Dispersive Liquid-Liquid Microextraction of Famotidine and Nizatidine from Water Samples. | 2019 Jan 1 |
2 |
| 9 |
29055278 | Enhanced Sensitivity to Detection Nanomolar Level of Cu2+ Compared to Spectrophotometry Method by Functionalized Gold Nanoparticles: Design of Sensor Assisted by Exploiting First-order Data with Chemometrics. | 2018 Feb 15 |
1 |
| 10 |
28532031 | Screening of process variables to enhance the solubility of famotidine with 2-HydroxyPropyl-β-Cyclodextrin & PVP K-30 by using Plackett-Burman design approach. | 2017 Aug 1 |
1 |
| 11 |
28690192 | Suppression of osteogenic differentiation in mesenchymal stem cells from patients with ossification of the posterior longitudinal ligament by a histamine-2-receptor antagonist. | 2017 Sep 5 |
5 |
| 12 |
27608003 | Molecular Encapsulation of Histamine H₂-Receptor Antagonists by Cucurbit[7]Uril: An Experimental and Computational Study. | 2016 Sep 6 |
1 |
| 13 |
25805997 | Physiological implications of biased signaling at histamine H2 receptors. | 2015 |
1 |
| 14 |
25277273 | Solid-state supramolecular synthesis based on the N-H…O heterosynthon: an approach to solve the polymorphism problem in famotidine. | 2014 Nov |
2 |
| 15 |
23467745 | Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function. | 2013 May |
1 |
| 16 |
23507526 | Quantum mechanical, spectroscopic studies (FT-IR, FT-Raman, NMR, UV) and normal coordinates analysis on 3-([2-(diaminomethyleneamino) thiazol-4-yl] methylthio)-N'-sulfamoylpropanimidamide. | 2013 May |
1 |
| 17 |
23637566 | Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor. | 2013 |
1 |
| 18 |
23881568 | Fixed-dose ibuprofen/famotidine: a review of its use to reduce the risk of gastric and duodenal ulcers in patients requiring NSAID therapy. | 2013 Sep |
2 |
| 19 |
22159514 | Solution-state NMR spectroscopy of famotidine revisited: spectral assignment, protonation sites, and their structural consequences. | 2012 Feb |
1 |
| 20 |
22183857 | Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study. | 2012 Apr |
1 |
| 21 |
22516788 | Incomplete activation of human eosinophils via the histamine H4-receptor: evidence for ligand-specific receptor conformations. | 2012 Jul 15 |
1 |
| 22 |
20380354 | Influence of chronic renal failure on acid secretion in isolated gastric mucosal cells from human biopsies. | 2010 |
1 |
| 23 |
19797865 | Famotidine neither affects action potential parameters nor inhibits human ether-a-go-go-related gene (hERG) K+ current. | 2009 Oct |
1 |
| 24 |
18600389 | A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease. | 2008 |
1 |
| 25 |
15496291 | Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A). | 2004 Oct 25 |
1 |
| 26 |
14671421 | Extremely early onset of ranitidine action on human histamine H2 receptors expressed in HEK293 cells. | 2003 |
2 |
| 27 |
10222548 | [The effect of histamine H2 receptor blockers on reparative processes in the gastric mucosa of patients with gastric peptic ulcer]. | 1999 |
1 |
| 28 |
10232696 | Effect of histamine H2-receptor antagonist on the phosphorus-binding abilities of calcium carbonate and calcium lactate in hemodialysis patients. | 1999 May |
1 |
| 29 |
8618582 | Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. | 1996 May 30 |
1 |
| 30 |
8701013 | Famotidine-associated delirium. A series of six cases. | 1996 Jul-Aug |
1 |
| 31 |
7925615 | Structural characteristics of histamine H2 receptor antagonists that scavenge hypochlorous acid. | 1994 Jun 15 |
1 |
| 32 |
8105512 | In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17). | 1993 Jul 23 |
1 |
| 33 |
1675461 | Histamine H2-receptor antagonists. | 1991 Jun |
1 |
| 34 |
1682955 | A method to assess histamine-induced cyclic AMP production in isolated gastric mucosal cells from human biopsies. | 1991 |
1 |
| 35 |
1764869 | Clinical pharmacokinetics of famotidine. | 1991 Sep |
1 |
| 36 |
1865643 | [Famotidine--a new histamine H2 receptor blockader]. | 1991 Apr |
1 |
| 37 |
1974182 | Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part I). | 1990 Jul |
1 |
| 38 |
2210613 | Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer. | 1990 Jul |
1 |
| 39 |
2566541 | Famotidine in the treatment of duodenal ulcers resistant to other histamine H2-receptor antagonists. | 1989 |
1 |
| 40 |
2571741 | Effects of famotidine, a new histamine H2-receptor antagonist, on renal function. | 1989 Jun |
1 |
| 41 |
2573505 | Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases. | 1989 Oct |
1 |
| 42 |
2902874 | Pharmacokinetics and dynamics of famotidine in patients with renal failure. | 1988 Sep |
1 |
| 43 |
2905936 | Optimal therapeutic regimen of famotidine based on plasma concentrations in patients with chronic renal failure. | 1988 |
1 |
| 44 |
3061768 | The significance of gastrin in the pathogenesis and therapy of peptic ulcer disease. | 1988 |
1 |
| 45 |
3394579 | Pharmacological control of the histamine H2 receptor-adenylate cyclase system by famotidine and ranitidine in normal and cancerous human gastric epithelia. | 1988 Apr |
1 |
| 46 |
2883883 | Effect of famotidine on hepatic hemodynamics and peptic ulcer. | 1987 May |
1 |
| 47 |
2887615 | Famotidine: effective treatment of Zollinger-Ellison syndrome. | 1987 |
1 |
| 48 |
2887616 | Clinical pharmacology of famotidine: a summary. | 1987 |
1 |
| 49 |
2889528 | Effect of a histamine H2-receptor antagonist, famotidine, on gastric secretion in healthy subjects. | 1987 |
1 |
| 50 |
2869182 | [Isolated human gastric mucosa cells--studies on physiologic and pharmacologic regulatory mechanisms]. | 1986 Jan 2 |
1 |